Guidant begins radiotherapy trials for restenosis
This article was originally published in Clinica
Human trials have begun using Guidant's radioactive treatment for restenosis, the re-narrowing of coronary arteries following coronary angioplasty or stent placement.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.